Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Julia Whitman"'
Autor:
Julia Whitman, Mark Sulkowski, Russell Rothman, Chris Lindsell, Jennifer Barrett, Thomas Stewart
Publikováno v:
Journal of Clinical and Translational Science, Vol 8, Pp 15-15 (2024)
OBJECTIVES/GOALS: As mortality and morbidity from acute COVID-19 decline, the impact of COVID-19 on short- and long-term quality of life (QoL) becomes critical to address. We assessed the impact of re-purposed COVID-19 therapies on QoL as a secondary
Externí odkaz:
https://doaj.org/article/8f6583be44f84c92a8f956b5d4d51954
Autor:
Katherine S Chen, Courtney Lawhn-Heath, Spencer Behr, Roxanna Juarez, Julia Whitman, Alan Paciorek, Eric K Nakakura, Nicholas Fidelman, Mary Uan-Sian Feng, Emily K Bergsland, Mekhail Anwar
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252574 (2021)
BackgroundNeuroendocrine neoplasms (NENs) comprise a rare and heterogenous group of cancers, for which the role of radiation therapy continues to evolve. The purpose of this study is to analyze oncologic outcomes after the use of high-dose radiation
Externí odkaz:
https://doaj.org/article/a51e61d9a56949b782014ffb3a6b6958
Autor:
Stephanie J. Wang, Julia Whitman, Alan Paciorek, Bryan Khuong Le, Eric K. Nakakura, Spencer C. Behr, Nancy Joseph, Li Zhang, Thomas A. Hope, Emily K. Bergsland
Publikováno v:
Journal of Neuroendocrinology. 35
Autor:
null Stephanie J. Wang, null Julia Whitman, null Alan Paciorek, null Bryan Khuong Le, null Eric K. Nakakura, null Spencer C. Behr, null Nancy Joseph, null Li Zhang, null Thomas A. Hope, null Emily K. Bergsland
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceec8e711fcc5628818604b83a8739f0
https://doi.org/10.1111/jne.13260/v3/response1
https://doi.org/10.1111/jne.13260/v3/response1
Autor:
Patrick W. McGarrah, Christoph R. Becker, Rujuta Gadgil, Jennifer A. Chan, Pamela L. Kunz, Nitya Raj, Emily K. Bergsland, David Chan, Alia Thawer, Virginia Kelly, Linda Wu, Diane Lauren Reidy, Kathleen Hornbacker, Thorvardur R. Halfdanarson, Simron Singh, Julia Whitman
Publikováno v:
Oncologist
Background Grade 3 gastroenteropancreatic neuroendocrine neoplasms (G3 GEPNENs) are often aggressive, and the optimal treatment is unclear for this subgroup of neuroendocrine neoplasms (NENs). Temozolomide (TEM)-based regimens have been increasingly
Autor:
Bryan Khuong Le, Patrick McGarrah, Alan Paciorek, Amr Mohamed, Andrea B. Apolo, David L. Chan, Diane Reidy-Lagunes, Haley Hauser, Jaydira D. Rivero, Julia Whitman, Kathleen Batty, Li Zhang, Nitya Raj, Tiffany Le, Emily Bergsland, Thorvardur R. Halfdanarson
Publikováno v:
Clinical Genitourinary Cancer. 21:403-414.e5
Autor:
Sarah E. Umetsu, Sanjay Kakar, Olca Basturk, Grace E. Kim, Deyali Chatterjee, Kwun Wah Wen, Gillian Hale, Nafis Shafizadeh, Soo-Jin Cho, Julia Whitman, Ryan M. Gill, Kirk D. Jones, Pooja Navale, Emily Bergsland, David Klimstra, Nancy M. Joseph
Publikováno v:
Modern Pathology. 36:100065
Publikováno v:
J Nucl Med
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 9
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 9
Hyperparathyroidism is an endocrine disorder caused by one or more hyperfunctioning parathyroid glands. Current imaging consisting of ultrasound and (99m)Tc-sestamibi is imprecise, making localization difficult. (18)F-fluorocholine ((18)F-FCH) PET ha
Autor:
Dung T. Le, Lawrence Fong, Adel Kardosh, Nancy M. Joseph, George A. Fisher, Courtney Onodera, Emily K. Bergsland, Thomas A. Hope, Luis A. Diaz, Julia Whitman
Publikováno v:
JCO Precision Oncology. :1-7
Autor:
Andrea Grace Bocobo, Renee Wang, Spencer Behr, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Lawrence Fong, Bridget P Keenan, Wesley Allen Kidder, Andrew H. Ko, Kanti Pallav Kolli, Megan Kennedy, Angela Laffan, Sorbarikor Piawah, Marin Pollak, Gabriel Schwartz, Julia Whitman, Li Zhang, Katherine Van Loon, Chloe Evelyn Atreya
Publikováno v:
Journal of Clinical Oncology. 40:3565-3565
3565 Background: MSS mCRC rarely responds to pembrolizumab monotherapy, but capecitabine and bevacizumab may induce immune-stimulatory effects. This study evaluates the safety, tolerability and preliminary efficacy of pembrolizumab in combination wit